Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-03-03 @ 12:38 AM
Study NCT ID:
NCT01773460
Status:
TERMINATED
Last Update Posted:
2016-02-10
First Post:
2013-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Sponsor:
GBG Forschungs GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |